AstraZeneca submits Brilinta for FDA approval

11/19/2009 | Reuters

AstraZeneca filed for FDA approval of Brilinta, a promising rival to blockbuster blood thinner Plavix. The application comes months after AstraZeneca reported that Brilinta outperformed Plavix in a late-stage study.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA